PAHC PHIBRO ANIMAL HEALTH CORP: institutional ownership and insider trading
227 funds reported holding $735M of PHIBRO ANIMAL HEALTH CORP in their latest 13F filings; in Q2 2026 funds net bought $20.8M, with 30 new positions and 80 funds selling out; over the last 12 months insiders bought $318K and sold $28.6M on the open market; over its last four quarters it reported revenue of $1.50B and net income of $95.2M.
PAHC revenue and earnings
- Quarter ended Mar 31, 2026: revenue $384M, net income $24.0M, EPS 0.59
- Quarter ended Dec 31, 2025: revenue $374M, net income $27.5M, EPS 0.67
- Quarter ended Sep 30, 2025: revenue $364M, net income $26.5M, EPS 0.65
- Quarter ended Jun 30, 2025: revenue $379M, net income $17.2M, EPS 0.43
Famous investors holding PAHC
- Renaissance Technologies (Renaissance Technologies): $15.1M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $29.4M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $856K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $719K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $543K, 0.0% of the portfolio
Largest institutional holders of PAHC
- BlackRock, Inc. (BLK) — $101M
- FMR LLC — $99.2M
- VANGUARD GROUP INC — $57.5M
- STATE STREET CORP (STT, STT-PG) — $32.6M
- MILLENNIUM MANAGEMENT LLC — $29.4M
- VANGUARD CAPITAL MANAGEMENT LLC — $29.0M
- GEODE CAPITAL MANAGEMENT, LLC — $20.6M
- LORD, ABBETT & CO. LLC — $20.5M
- DIMENSIONAL FUND ADVISORS LP — $16.7M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $16.0M
Recent PAHC insider trades
- May 29, 2026: Corcoran E Thomas bought 10,000 shares ($318K)
- May 7, 2026: Bendheim Jack sold 18,608 shares ($1.02M)
- Apr 30, 2026: Bendheim Jack sold 21,120 shares ($1.14M)
- Apr 23, 2026: Bendheim Jack sold 21,120 shares ($1.16M)
5%+ owners
- BFI Co., LLC: 48.2% (Schedule 13D/A, filed May 22, 2026)
- FMR LLC: 15.0% (Schedule 13G/A, filed Aug 6, 2026)
- Vanguard Capital Management: 5.1% (Schedule 13G, filed Apr 30, 2026)